The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Pharmacokinetics of the Dietary Supplement Creatine
Abstract
Creatine is a nonessential dietary component that, when supplemented in the diet, has shown physiological benefits in athletes, in animal-based models of disease and in patients with various muscle, neurological and neuromuscular disease. The clinical relevance of creatine supplementation is based primarily on its role in ATP generation, and cells may be able to better handle rapidly changing energy demands with supplementation. Although the pharmacological outcome measures of creatine have been investigated, the behaviour of creatine in the blood and muscle is still not fully understood. Creatine is most probably actively absorbed from the gastrointestinal tract in a similar way to amino acids and peptides. The distribution of creatine throughout the body is largely determined by the presence of creatine transporters. These transporters not only serve to distribute creatine but serve as a clearance mechanism because of creatine 'trapping' by skeletal muscle. Besides the pseudo-irreversible uptake by skeletal muscle, creatine clearance also depends on renal elimination and degradation to creatinine. Evidence suggests that creatine pharmacokinetics are nonlinear with respect to dose size and frequency. Skeletal muscle, the largest depot of creatine, has a finite capacity to store creatine. As such, when these stores are saturated, both volume of distribution and clearance can decrease, thus leading to complex pharmacokinetic situations. Additionally, other dietary components such as caffeine and carbohydrate can potentially affect pharmacokinetics by their influence on the creatine transporter. Disease and age may also affect the pharmacokinetics, but more information is needed. Overall, there are very limited pharmacokinetic data available for creatine, and further studies are needed to define absorption characteristics, clearance kinetics and the effect of multiple doses. Additionally, the relationship between plasma creatine and muscle creatine needs to be elucidated to optimise administration regimens.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Therefore, the conversion of creatine to creatinine in the gastrointestinal tract is minimal regardless of transit time; absorption into the blood is nearly 100%”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [57]
In the citing paper
“less than 1% of creatine monohydrate is degraded to creatinine during the digestive process and creatine is taken up by tissue or excreted in urine after ingestion [60, 185–187].”
From Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? (2021) · cites this paper as [186]
In the citing paper
“it is well established that ~99% of orally ingested creatine monohydrate is either taken up by tissue or excreted in the urine as creatine through normal digestion [60, 185, 186].”
From Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? (2021) · cites this paper as [186]
In the citing paper
“The conversion of creatine to creatinine in the gastrointestinal tract is minimal regardless of transit time (Persky et al. 2003; Harris et al. 1992b; Deldicque et al. 2008).”
From Analysis of the efficacy, safety, and regulatory status of novel forms of creatine (2011) · cites this paper as Persky et al. 2003
In the citing paper
“Research has clearly shown that CrM is not degraded into creatinine during normal digestion, it is nearly 100% bioavailable [12,25,58,59], and markedly increases blood and tissue creatine content.”
From Bioavailability, Efficacy, Safety, and Regulatory Status of Creatine and Related Compounds: A Critical Review (2022) · cites this paper as [58]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950
Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation
Harris, R. C., Söderlund, K., & Hultman, E. (1992) · Clinical Science · doi:10.1042/cs0830367 · Cited by 1,168 · cited 10×
“For example, with the first out.[4] The hydrophilic nature of creatine means that dose, creatine clearance can rely on both muscle and it would generally be thought of as ‘permeability- kidney, but after a number of doses, when muscle limited’ with regards to distribution.”
BackgroundInfluentialHarris, R. C., Hultman, E., & Nordesjö, L. O. (1974) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365517409082477 · Cited by 849
Muscle creatine loading in men
Hultman, E., Soderlund, K., Timmons, J. A., Cederblad, G., & Greenhaff, P. L. (1996) · Journal of Applied Physiology · doi:10.1152/jappl.1996.81.1.232 · Cited by 822
Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
Klivenyi, P., Ferrante, R. J., Matthews, R. T., Bogdanov, M. B., Klein, A. M., Andreassen, O. A., Mueller, G., Wermer, M., Kaddurah-Daouk, R., & Beal, M. F. (1999) · Nature Medicine · doi:10.1038/6568 · Cited by 682 · cited 1×
“Amyotrophic lateral sclerosis[10,11] Arthritis[12] Congestive heart failure[13-15] Disuse atrophy[16] Gyrate atrophy[17-19] Huntington’s disease[20-22] McArdles disease[23,24] Miscellaneous neuromuscular diseases[25-27] Mitochondrial diseases[28-30] Muscular dystrophy[31-34] Neuroprotection[35-42]”
BackgroundEffect of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis
Greenhaff, P. L., Bodin, K., Soderlund, K., & Hultman, E. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.5.e725 · Cited by 531
Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease
Ferrante, R. J., Andreassen, O. A., Jenkins, B. G., Dedeoglu, A., Kuemmerle, S., Kubilus, J. K., Kaddurah-Daouk, R., Hersch, S. M., & Beal, M. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04389.2000 · Cited by 522
AAEM minimonograph #26: The electrodiagnosis of carpal tunnel syndrome
Stevens, J. C. (1997) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199712)20:12 · Cited by 518
Creatine: Biosynthesis, Regulation, and Function
Walker, J. B. (1979) · Advances in Enzymology - and Related Areas of Molecular Biology · doi:10.1002/9780470122952.ch4 · Cited by 496
Greenhaff, P. L., Casey, A., Short, A. H., Harris, R., Soderlund, K., & Hultman, E. (1993) · Clinical Science · doi:10.1042/cs0840565 · Cited by 460
Research works printed but not linked: 6
- Vanakoski, 1998, Int J Clin Pharmacol Ther, 36, 258
- Gordon, 1995, Cardiovasc Res, 30, 413, 10.1016/S0008-6363(95)00062-3 · doi:10.1016/s0008-6363(95)00062-3 · Paper page
- Hagenfeldt, 1994, Muscle Nerve, 17, 1236
- Tarnopolsky, 1997, Muscle Nerve, 20, 1502, 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C · DOI · Paper page
- Nash, 1994, Receptors Channels, 2, 165
- Boroujerdi, 1986, Res Commun Chem Pathol Pharmacol, 53, 361
Cited by
Kreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057
“Therefore, the conversion of creatine to creatinine in the gastrointestinal tract is minimal regardless of transit time; absorption into the blood is nearly 100% [10, 53, 56, 57].”
BackgroundCreatine supplementation with specific view to exercise/sports performance: An update
Cooper, R., Naclerio, F., Allgrove, J., & Jimenez, A. (2012) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-9-33 · Cited by 306
“charged functional group [64].”
Antonio, J., Candow, D. G., Forbes, S. C., Gualano, B., Jagim, A. R., Kreider, R. B., Rawson, E. S., Smith-Ryan, A. E., VanDusseldorp, T. A., Willoughby, D. S., et al. (2021) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-021-00412-w · Cited by 345
“Additionally, it is well established that ~99% of orally ingested creatine monohydrate is either taken up by tissue or excreted in the urine as creatine through normal digestion [60, 185, 186].”
BackgroundHydration biomarkers in free-living adults with different levels of habitual fluid consumption
Perrier, E., Vergne, S., Klein, A., Poupin, M., Rondeau, P., Le Bellego, L., Armstrong, L. E., Lang, F., Stookey, J., & Tack, I. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512003601 · Cited by 171
“Creatinine is continually produced from the degradation of creatine and phosphocreatine((33,34)).”
BackgroundCreatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?
Allen, P. J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.03.005 · Cited by 163
“…of creatine over a prolonged period of time results in measurable increases of creatine concentrations in brain and muscle tissue, which is most pronounced after 4 weeks (Dechent et al., 1999; Ferrante et al., 2000; Ipsiroglu et al., 2001; Persky et al., 2003a, b; Stöckler et al., 1996).”
Background
Metadata
- Authors
- Persky, A. M., Brazeau, G. A., & Hochhaus, G.
- Affiliations
- University of Florida (US)
- University at Buffalo, State University of New York (US)
- Corresponding author
- Persky, Adam M
- Venue
- Clinical Pharmacokinetics
- Published
- 2003
- Volume
- 42
- Issue
- 6
- Pages
- 557-574
- ISSN
- 0312-5963 (ISSN-L)
- OpenAlex
- W2012306132
- Cited by
- 132
- References
- 119
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 12 · 2023: 5 · 2022: 9 · 2021: 8 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 5 · 2016: 1 · 2015: 6 · 2014: 8 · 2013: 7 · 2012: 10
- FWCI
- 0.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Pharmacokinetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Health Sciences › Medicine › Physiology (medical) › Biochemical effects in animals
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- creatine, creatine supplementation, pharmacokinetics, creatine transporter, renal excretion, creatinine, nonlinear dose-response relationship, caffeine, carbohydrates, plasma creatine, muscle creatine, energy metabolism
- MeSH terms
- Absorption, Administration, Oral, Animals, Caffeine, Creatine, Dietary Carbohydrates, Drug Interactions, Female, Humans, Kidney, Male, Metabolic Clearance Rate, Muscle, Skeletal, Dietary Supplements, Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacokinetics of the Dietary Supplement Creatine. https://app.cochat.ai/papers/10.2165/00003088-200342060-00005
- The paper
- Persky, A. M., Brazeau, G. A., & Hochhaus, G. (2003). Pharmacokinetics of the Dietary Supplement Creatine. Clinical Pharmacokinetics. https://doi.org/10.2165/00003088-200342060-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.